InvestorsHub Logo
Followers 23
Posts 8762
Boards Moderated 0
Alias Born 10/17/2015

Re: None

Wednesday, 10/31/2018 5:00:15 PM

Wednesday, October 31, 2018 5:00:15 PM

Post# of 39183
There is actually marketing in the report(?)! See In Bold. The latest financial report fails to explain what the products do, and/or are. Adding that and some imagery actually creates a simple message for homeopathic sites. The explanation that the patent rights are fully assigned to Itonis Inc., would also be included. If there are homeopathic cannabis sites, then that works too.

The Company is presently focused on marketing its Emesyl® homeopathic anti-nausea and its Emesyl® Plus products for retail sale. Presently, Emesyl®The Company is presently focused on marketing its Emesyl® homeopathic anti-nausea and its Emesyl® Plus products for retail sale.

Presently, Emesyl® is available for sale at https://www.amazon.com/dp/B00U20H3KI and www.Emesyl.com, and Emesyl® Plus is available for sale at https://www.amazon.com/dp/B07H2Z9BHS.

The Company is engaged in efforts to expand all marketing and sales, as well as additional Emesyl®-branded products.

Maybe they are making something of the branded products concept(?).